id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-N-1111-0003,FDA,FDA-2024-N-1111,"PRIA Ref 1 - U.S Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, ""Guidelines for Regulatory Impact Analysis,"" 2016.",Supporting & Related Material,Background Material,2024-08-19T04:00:00Z,2024,8,,,2024-08-19T13:07:43Z,,0,0,090000648664c5f8
FDA-2024-N-1111-0002,FDA,FDA-2024-N-1111,"FDA, Submission of Food and Drug Administration Import Data in the Automated Commercial Environment (Proposed Rule) Preliminary Regulatory
Impact Analysis. Economic Impact Analyses of FDA Regulations.",Supporting & Related Material,Background Material,2024-08-19T04:00:00Z,2024,8,,,2024-08-19T13:07:20Z,,0,0,090000648664c5f7
FDA-2024-N-1111-0001,FDA,FDA-2024-N-1111,Submission of Food and Drug Administration Import Data in the Automated Commercial Environment for Certain Tobacco Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2024-08-16T04:00:00Z,2024,8,2024-08-16T04:00:00Z,2024-10-16T03:59:59Z,2024-10-17T01:01:14Z,2024-18343,0,0,090000648664dc6c